We are live on ! Find out more
RGEN icon

Repligen

443 hedge funds and large institutions have $7.22B invested in Repligen in 2025 Q2 according to their latest regulatory filings, with 74 funds opening new positions, 130 increasing their positions, 173 reducing their positions, and 70 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.35% more ownership

Funds ownership: 102.58%103.93% (+1.4%)

6% more first-time investments, than exits

New positions opened: 74 | Existing positions closed: 70

0% more funds holding

Funds holding: 441443 (+2)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

2% less capital invested

Capital invested by funds: $7.37B → $7.22B (-$151M)

25% less repeat investments, than reductions

Existing positions increased: 130 | Existing positions reduced: 173

88% less call options, than puts

Call options by funds: $10.2M | Put options by funds: $84.6M

Holders
443
Holders Change
+2
Holders Change %
+0.45%
% of All Funds
5.83%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
74
Increased
130
Reduced
173
Closed
70
Calls
$10.2M
Puts
$84.6M
Net Calls
-$74.4M
Net Calls Change
-$16.8M

RGEN Hedge Fund Activity: Q2 2025 in Review

443 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Repligen (RGEN) for Q2 2025, worth a combined $7.22B — down 2.1% from $7.37B a quarter earlier.

Buyers outnumbered sellers: 74 funds opened new RGEN positions and 70 closed out — a net gain of 4 holders — while 130 added to existing stakes and 173 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $112M. The largest seller was T. Rowe Price Associates, cutting an estimated $122M.

  • 443 institutional investors held Repligen (RGEN) as of Q2 2025, up from 441 in Q1 2025.
  • Funds reported $7.22B of Repligen stock for Q2 2025, down 2.1% quarter-over-quarter.
  • 74 funds opened new Repligen positions in Q2 2025 and 70 closed out, a net change of +4 holders.
  • The largest Repligen buyer in Q2 2025 was Fidelity Investments, an estimated $112M added.
  • The largest Repligen seller in Q2 2025 was T. Rowe Price Associates, an estimated $122M sold.

Based on aggregated 13F filings for Q2 2025.